Clinical Trials Browser

Phase 2 × INDUSTRY × Transplantation, Autologous × Clear all

NCT01660633 2020-04-21

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Phase 2 Completed

Multiple Myeloma